A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine
a_novel_anti-HER2_2019.pdf
(Tampereen yliopisto - Trepo)
Tallennettuna:
Kieli |
englanti |
---|---|
Aiheet | |
ISSN |
1538-8514 |